Journals / Nöropsikiyatri Arşivi / 2012 / Cilt: 49 - Sayı: 2

Epilepsi tedavisi alan kadın hastalarda hipotalamo-pituiter-gonadal aksın değerlendirilmesi

Investigation of hypothalamus-pituitary-gonadal axis in epileptic women reated for epilepsy

Pages
133–138
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Those patients had increased ovarian stroma and hormonal activity characterized by hyperandrogenemia, as demonstrated by buserelin testing and insulin resistance as demonstrated by OGTT.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Reproductive endocrine disorders, especially polycystic ovary syndrome (PCOS) are common in epileptic women who are less fertile and suffer from more menstrual and reproductive endocrine disorders than non-epileptic women.
📊
Key Findings & Data:Method: This study included 48 epileptic women with a mean age of 24.2±5.5 years.
💡
Conclusion & Impact:Those patients had increased ovarian stroma and hormonal activity characterized by hyperandrogenemia, as demonstrated by buserelin testing and insulin resistance as demonstrated by OGTT.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Valproik asit · Epilepsi · Kadın

Abstract

Objectives: Reproductive endocrine disorders, especially polycystic ovary syndrome (PCOS) are common in epileptic women who are less fertile and suffer from more menstrual and reproductive endocrine disorders than non-epileptic women. The etiology of reproductive endocrine dysfunction in epilepsy has not been determined precisely. The aim of the study was to investigate the hypotalamus-pituitary-gonadal axis, insulin resistance and the prevalence of PCOS in patients with generalized idiopathic or cryptogenic epilepsy and receiving treatment with valproate (VPA) and carbamazepine (CBZ). Method: This study included 48 epileptic women with a mean age of 24.2±5.5 years. The patient groups consisted of 34 (70.8%) women with epilepsy on VPA and 14 (29.2%) women with epilepsy on CBZ. The control group consisted of 20 healthy women. Fasting blood samples were obtained for the determination of glucose, insulin, gonadotrophins, estradiol, androgens, 17-OH progesteron (17- OHP), and sex hormone-binding globulin (SHBG) levels. All subjects underwent oral glucose tolerance test (OGTT) and the buserelin stimulation test for glucose tolerance status, insulin resistance parameters and hypothalamus-pituitarygonadal axis evaluation. Results: PCOS was diagnosed in 17 (35.4%) epileptic patients and glucose intolerance was found in two (4.1%) patients. Basal insulin levels, glucose and insulin responses to OGTT were significantly higher in the patients than in the controls. Peak and area under curve (AUC) 17-OHP responses to the buserelin stimulation test were significantly higher in the patients than in the controls. Discussion: The prevalence of PCOS among women with epilepsy receiving VPA or CBZ treatment was higher than expected. Those patients had increased ovarian stroma and hormonal activity characterized by hyperandrogenemia, as demonstrated by buserelin testing and insulin resistance as demonstrated by OGTT.

Özet

Amaç: Fertiliteleri nonepileptik kadınlara göre daha az olan epileptik kadınlarda özellikle polikistik over sendromu (PKOS) olmak üzere, menstruel ve reprodüktif endokrin bozukluklar yaygındır. Epilepsili hastalarda görülen endokrin disfonksiyonun etiyolojisi kesin olarak bilinmemektedir. Yön­tem­ler: Bu çalışmanın amacı valproat (VPA) ve karbamazepin (KBZ) tedavisi alan jeneralize idiopatik ve kriptojenik epilepsili hastalarda hipotalamo-pitüiter-gonadal aksın, insulin rezistansı ve PKOS prevalansının araştırılmasıdır. Bul­gu­lar: Hasta grubu 48 epilepsili kadın hastadan (ortalama yaş 24,2±5,5) oluşmakta idi. Hastaların 34’ü (%70,8) VPA, 14’ü (%29,2) KBZ kullanmakta idi. Kontrol grubu 20 sağlıklı kadından oluşmakta idi. Glukoz, insulin, gonadotropinler, östradiol, androjenler, 17-OH progesterone ve seks hormone bağlayan globulin seviyelerinin ölçümü için açlık kan örnekleri alındı. Tüm deneklerde oral glukoz tolerans testi, insulin rezistans parametreleri ve hipotalamo-pitüter-gonadal aksın değerlendirilmesi yapıldı. So­nuç: PKOS; 17 epileptik kadında (%35,4), glukoz intoleransı 2 hastada (%4,1) bulundu. Bazal insulin düzeyleri, OGTT testine glukoz ve insulin yanıtları hasta grubunda anlamlı olarak yüksekti. Buserelin testine 17-OH progesteronun pik ve eğri altında kalan alan yanıtı hasta grubunda anlamlı olarak yüksekti. Valproat ve KBZ kullanan epilepsili hastalarda PKOS prevalansı beklenenden yüksekti. Bu hastalar buserelin testi ile gösterilen artmış ovarian stroma ve hiperandrojenemi ile karakterize artmış hormonal aktiviteye sahip idi. OGTT ise artmış insulin resistansının varlığını göstermekteydi. PKOS prevalansı , idiopatik ve kriptojenik epilepsili CBZ ve VPA tedavisi alan kadınlarda beklenenden yüksek oranda saptandı. OGTT artmış insülin rezistansının varlığını gösterdi.

🔖

Cite This Article

ERDOĞAN, F. F., ARIK, S. Y., ERSOY, A. Ö., ÜNLÜHIZARCI, K., TANRIVERDİ, F., KELEŞTİR, F. (2012). Epilepsi tedavisi alan kadın hastalarda hipotalamo-pituiter-gonadal aksın değerlendirilmesi. Nöropsikiyatri Arşivi, Cilt: 49 - Sayı: 2, 133–138. https://ajindex.com/articles/292515

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Luef G, Abraham I, Haslinger M, Trinka E, Seppi K, Unterberger I, Alge A, Windisch J, Lechleitner M, Bauer G. Polycystic ovaries, obesity, and insulin resistance in women with epilepsy: A comparative study of carbamazepine and valproic acid in 105 women. J Neurol 2002; 249:835-841
  2. Morrell MJ, Isojärvi J, Taylor AE, Dam M, Ayala R, Gomez G, O'Neill F, Tennis P, Messenheimer J. Higher androgens and weight gain with valproate compared with lamotrigine for epilepsy. Epilepsy Res 2003; 54:189-199
  3. Taubøll E, Wójtowicz AK, Ropstad E, Gregoraszczuk EL. Valproate irreversibly alters steroid secretion patterns from porcine follicular cells in vitro. Reprod Toxicol 2002; 16:319-325
  4. Bilo L, Meo R. Polycystic ovary syndrome in women using valproate: A review. Gynecol Endocrinol 2008; 24:562-570
  5. Herzog AG, Friedman MN. Menstrual cycle interval and ovulation in women with localization-related epilepsy. Neurology 2002; 57:2133-2135
  6. Bauer J, Isojärvi JI, Herzog AG, Reuber M, Polson D, Taubøll E, Genton P, van der Ven H, Roesing B, Luef GJ, Galimberti CA, van Parys J, Flügel D, Bergmann A, Elger CE. Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management. J Neurol Neurosurg Psychiatry 2002; 73:121-125
  7. Scharfman HE, Kim M, Hintz TM, MacLusky NJ. Seizures and reproductive function: insight female rats with epilepsy. Ann Neurol 2008; 64:687-697
  8. Dunaif A. Insulin resistance and polycystic ovary syndrome: mechanism and implication for pathogenesis. Endocr Rev 1997; 18:774-800
  9. Conway GS, Agrawal R, Betteridge DJ, Jacobs HS. Risk factors for coronary artery disease in lean and obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 1992; 37:119-125
  10. Polson DW. Polycystic ovary syndrome and epilepsy-a gynaecological perspective. Seizure 2003; 12:397-402
  11. Cynthia LH. Polycystic ovaries and polycystic ovary syndrome in epilepsy:Evidence for neurogonadal disease. Epilepsy Curr 2005; 5:142-146
  12. Rasgon N. The relationship between polycystic ovary syndrome and antiepileptic drugs. Areview of the evidence. J Clin Psychopharmacol 2004; 24:322-334
  13. Harden CL. Polycytic ovaries and polycytic ovary syndrome in epilepsy: evidence for neurogonadal disease. Epilepsy Curr 2005; 5:142-146
  14. Isojärvi JI, Laatikainen TJ, Pakarinen AJ, Juntunen KT, Myllylä VV. Menstrual disorders in women with epilepsy receiving carbamazepine. Epilepsia 1995; 36:676-681
  15. Isojärvi JI, Taubøll E, Pakarinen AJ, van